TipRanks on MSN4h
Alkermes price target raised to $35 from $34 at BofA
BofA raised the firm’s price target on Alkermes (ALKS) to $35 from $34 and keeps a Neutral rating on the shares. The firm’s higher target reflects a higher P/E multiple given recent moves in peer ...
Khloé and Kim Kardashian share details about Anant Ambani and Radhika Merchant’s lavish Indian wedding
Sisters Khloé and Kim Kardashian grapple with jet lag and differing sleep habits during their trip to Mumbai for a ...
Khloé Kardashian Reveals the 'Rare Gift' Her Sister Kim Has That Makes Her Envious
In the latest episode of 'The Kardashians,' Kim displayed her gift while the sisters traveled to Mumbai, India, to attend a ...
Singapore Armodafinil hospitalisation: Indian pharma company claims ‘never supplied drug outside country’
Dehradun: An Indian pharmaceutical firm, whose products Singapore's Health Sciences Authority (HSA) allegedly issued images ...
Khloé Kardashian Is Convinced Kim Has This Undiagnosed Disorder
Khloé Kardashian made a bold diagnosis for her sister Kim on the latest episode of Hulu's The Kardashians.
Community Connection – Sleep Disorders
Call him Dr. Sleep. David A. Cohen, MD, is the Section Chief of Sleep Medicine for St. Luke’s. A trip to the sleep doctor can ...
Alkermes initiated with a Sector Perform at RBC Capital
RBC Capital initiated coverage of Alkermes (ALKS) with a Sector Perform rating and $40 price target The company’s next-generation orexin has a ...